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Abstract
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly adopted for the
treatment of cardiogenic shock (CS). However, a marker of successful weaning remains largely unknown. Our
hypothesis was that successful weaning is associated with sustained microcirculatory function during ECMO flow
reduction. Therefore, we sought to test the usefulness of microcirculatory imaging in the same sublingual spot,
using incident dark field (IDF) imaging in assessing successful weaning from VA-ECMO and compare IDF imaging
with echocardiographic parameters.
Methods: Weaning was performed by decreasing the VA-ECMO flow to 50% (F50) from the baseline. The endpoint
of the study was successful VA-ECMO explantation within 48 hours after weaning. The response of sublingual
microcirculation to a weaning attempt (WA) was evaluated. Microcirculation was measured in one sublingual area
(single spot (ss)) using CytoCam IDF imaging during WA. Total vessel density (TVDss) and perfused vessel density
(PVDss) of the sublingual area were evaluated before and during 50% flow reduction (TVDssF50, PVDssF50) after a WA
and compared to conventional echocardiographic parameters as indicators of the success or failure of the WA.
Results: Patients (n = 13) aged 49 ± 18 years, who received VA-ECMO for the treatment of refractory CS due to
pulmonary embolism (n = 5), post cardiotomy (n = 3), acute coronary syndrome (n = 2), myocarditis (n = 2) and drug
intoxication (n = 1), were included. TVDssF50 (21.9 vs 12.9 mm/mm
2, p = 0.001), PVDssF50 (19.7 vs 12.4 mm/mm
2,
p = 0.01) and aortic velocity–time integral (VTI) at 50% flow reduction (VTIF50) were higher in patients successfully
weaned vs not successfully weaned. The area under the curve (AUC) was 0.99 vs 0.93 vs 0.85 for TVDssF50
(small vessels) >12.2 mm/mm2, left ventricular ejection fraction (LVEF) >15% and aortic VTI >11 cm. Likewise, the
AUC was 0.91 vs 0.93 vs 0.85 for the PVDssF50 (all vessels) >14.8 mm/mm
2, LVEF >15% and aortic VTI >11 cm.
Conclusion: This study identified sublingual microcirculation as a novel potential marker for identifying successful
weaning from VA-ECMO. Sustained values of TVDssF50 and PVDssF50 were found to be specific and sensitive
indicators of successful weaning from VA-ECMO as compared to echocardiographic parameters.
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Background
Cardiogenic shock (CS) associated with cardiac pump
failure results in a state of inadequate tissue perfusion,
which leads to organ failure with a mortality rate be-
tween 50 and 80% [1]. Veno-arterial extracorporeal
membrane oxygenation (VA-ECMO) is considered a life-
saving treatment that is increasingly used for the treat-
ment of critically ill patients that have experienced CS
[2–4]. However, mortality rates remain high, with
reports of up to 44% mortality despite the use of
VA-ECMO [1, 5].
Current strategies for weaning from VA-ECMO are
ongoing, largely unknown and based on empirical evi-
dence [6–8]. Most of the current markers of weaning
from VA-ECMO are based on echocardiography, such as
aortic velocity–time integral (VTI), left ventricular ejec-
tion fraction (LVEF), and tissue Doppler lateral mitral
annulus peak systolic velocity (TDSa) [9]. However, per-
forming high-quality echocardiography in critically ill
patients requires specialized training and is relatively
costly [10].
In a recent study, we found that the initial inability of
VA-ECMO to recruit the microcirculatory alteration as-
sociated with CS predicts adverse outcomes following
VA-ECMO treatment irrespective of improved systemic
hemodynamic parameters [11]. This is based on the con-
cept that the success of resuscitation from states of cir-
culatory shock is the normalization of microcirculatory
and tissue perfusion [12, 13].
It is known that there is possibly a loss of coherence
between the systemic and microcirculation, which can
occur in states of shock and resuscitation [14]. Previous
studies measuring sublingual microcirculation using
hand-held video microscopy have shown impairment of
sublingual microcirculation to be associated with CS
[12, 13, 15]. In addition, studies have found that
sustained microcirculatory perfusion by VA-ECMO as
detected by handheld video microscopes is associated with
lower morbidity and even mortality [12, 14].
Our hypothesis was that successful weaning is associated
with sustained microcirculatory function during ECMO
flow reduction. Therefore, we sought to test the usefulness
of microcirculatory imaging in the same sublingual spot,
using incident dark field (IDF) imaging in assessing
successful weaning from VA-ECMO and to compare IDF
imaging with echocardiographic parameters [7].
Methods
Study population
The institutional medical ethics board of the Erasmus
Medical Center approved this study under protocol
number NL45915.078.13, and informed consent was
obtained from all patients and/or legal representatives. Be-
tween October 2014 and January 2016, our prospective
observational study included all eligible patients under
VA-ECMO support admitted to the Intensive Care Unit
of our center, a tertiary and national referral center for
end-stage heart failure, heart transplantation and left ven-
tricular assist devices. Inclusion criteria were > 18 years
old and need for VA-ECMO due to any form of refractory
cardiogenic shock. Exclusion criteria were being moribund
and refusal to participate in the study (Fig. 1).
Echocardiography
Acquisition
Transthoracic echocardiography (TTE) and/or trans-
esophageal (TEE) echocardiography was performed during
weaning attempts using the CX50 ultrasound system
(Philips Medical System, Best, The Netherlands). Pulsed-
wave and continuous-wave Doppler signals were recorded
at a sweep speed of 50–100 mm/s. Color Doppler record-
ings were optimized for display with the color velocity
scale at ± 60 (50–70 cm/s) during the entire study.
Analysis
All echocardiograms were analyzed by two experienced
echo cardiologists (OS and SA), in accordance with pub-
lished guidelines [16], using the QLAB quantification
software (Philips Healthcare, Best, The Netherlands).
Aortic VTI was measured by manually tracing the spec-
tral envelope of continuous-wave Doppler in the apical
5-chamber or 3-chamber view. The LVEF was visually
estimated from apical views. The right ventricular func-
tion was assessed by measuring the tricuspid annular
planer systolic excursion (TAPSE) from the M-mode
images in the apical 4-chamber view. Tissue Doppler
lateral mitral annulus peak systolic velocity (TDSa) was
also measured when feasible.
Weaning strategy
Weaning from VA-ECMO was initiated in patients with
persistently stable hemodynamics (mean arterial pres-
sure > 60 mmHg, lactate < 2 mmol/L and mixed venous
saturation values > 65%) and with persisting arterial
pulsatility wave on the monitor under low doses of
inotropic support (Fig. 1). Weaning was performed by
lowering the blood flow to 50% of the baseline value
under hemodynamic and echocardiographic surveillance.
Persisting hemodynamic stability was defined as aortic
VTI > 10 cm and estimated LVEF > 20–25% [7, 9]. Pa-
tients who recovered from severe cardiac dysfunction
and who tolerated the weaning attempt were considered
for device removal [7].
Microcirculatory imaging
Acquisition Sublingual microcirculation was measured
independently of echocardiography data during the same
weaning attempt, just before or after echocardiography,
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at baseline (100%) VA-ECMO flow (F100), and after re-
ducing VA-ECMO flow to 50% of the baseline flow
(F50) and at returning VA-ECMO flow to baseline after
2 minutes (F100). We performed these measurements
just before or after the classical weaning attempt using
echocardiography. These microcirculatory data were not
used to drive ECMO management.
Such a weaning attempt was followed by microcircula-
tory measurements during a weaning attempt, which
took a maximum of 10 minutes in total. All aspects of
microcirculatory measurements were performed as
stable video recordings with a duration of 3–5 seconds
by placing the CytoCam IDF imaging camera (Braedius
Medical, Huizen, The Netherlands) [17] in the same sub-
lingual area during the entire procedure, with total vessel
density measured at a single spot (TVDSS).
The IDF device consists of a computer-controlled,
high-resolution image sensor in combination with a spe-
cifically designed microscope lens at the end of an image
guide, covered by a disposable sterile cap. Placing the tip
of the guide to the sublingual tissue surface provides
high-resolution images of the microcirculation where
red blood cells can be clearly visualized flowing through
the microvessels.
This device is based on IDF imaging technique as de-
scribed by Sherman et al. [18]. Sidestream dark field
(SDF) technique optically isolates the incoming light
from the reflected while IDF illuminates the field in a
non-homogeneous fashion according to dark field. In
this CytoCam device, there are prominent technical
improvements such as digital signal, lower weight, and
higher optical resolutions, compared to previous devices.
In Fig. 2 and Additional file 1: Table S1 we show the vis-
ual and characteristic differences between SDF and IDF
technique as adapted. from van Elteren et al. [19].
This new iteration of the device with improved optics
detects 30% more sublingual vessels than the previous
generation microscope [17, 19, 20]. Microcirculatory
parameters are quantified by analyzing the movies using
specialized image processing software (Automated
Vascular Analysis (AVA)) [21].
Analysis
Two microcirculation experts (SA and GG) independ-
ently analyzed all microcirculation parameters based on
international consensus on the quantification of sublin-
gual microcirculatory alterations [22]. The images were
analyzed to determine the functional parameters of large
microvessels (> 25 μm) and small vessels (≤ 25 μm).
These parameters consisted of the TVD (mm/mm2); per-
fused vessel density (PVD (mm/mm2)); and proportion of
perfused vessels (PPV (%)) in accordance with inter-
national consensus guidelines related to the quantification
of such microcirculatory images [22]. Microcirculatory
measurements were compared with echocardiography pa-
rameters (LVEF, aortic VTI and TDSa, if available) and
used to evaluate the last weaning procedure as described
by Aissaoui et al. [7].
Statistics
Categorical variables are presented as frequencies and
percentages. Continuous variables are presented as the
Fig. 1 Flow chart for inclusion for weaning attempts and their outcomes (n = 13). VA-ECMO, veno-arterial extracorporeal membrane oxygenation;
VTI, velocity − time integral; LVEF, left ventricular ejection fraction; HD, Hemodynamic; RVF, Right ventricular function
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mean ± standard deviation (SD). Continuous variables
were compared with the Mann-Whitney U test. For
comparisons within the same group, the microcircula-
tory parameters of patients at different time points were
analyzed using the Friedman and Wilcoxon test. To
compare the microcirculatory parameters of patients
successfully weaned (SW) and not successfully weaned
(NSW) at different time points, the generalized linear
model repeated measurements test was used. Spearman’s
correlation analysis was used to compare the correlation
between echocardiographic and microcirculatory param-
eters in SW and NSW patients. Statistical significance
was defined by a p value <0.05. Analyses were performed
using SPSS version 21.0.0.1 (SPSS, IBM, Armonk, NY,
USA) and MedCalc (MedCalc, Ostend, Belgium) software.
Results
The study population consisted of 13 patients with cardio-
genic shock, 49 ± 18 years old, 11 of whom (85%) were
male. Of the 13 patients, 10 were SW from VA-ECMO
(Fig. 1). The causes of admission were pulmonary embol-
ism (n = 5, 38%), post cardiotomy (n = 3, 23%), acute cor-
onary syndrome (n = 2, 15%), myocarditis (n = 2, 15%) and
drug intoxication (n = 1, 8%) (Table 1). In total, 19 wean-
ing attempts were performed in 13 patients, of which 10
were successful and led to cardiac recovery (CR): 8 out of
10 were SW after the first attempt. Five patients need
more than one weaning attempt (Fig. 1). In the nine
unsuccessful weaning attempts, three patients died (non-
cardiac recovery; NCR) after six unsuccessful weaning
attempts and two patients were SW after two and three
attempts, respectively.
The global hemodynamics were not significantly dif-
ferent between SW and NSW patients during weaning
attempts (Additional file 2: Figure S1A and S1B).
Successful and unsuccessful weaning was classified ac-
cording to echocardiographic assessment as described
previously. The results from the microcirculation mea-
surements showed that in SW patients, TVDss, PVDss
and PPVss measured in the same sublingual area
Fig. 2 Technical differences between sidestream dark field (SDF) and incident dark field (IDF) technique adapted with permission from reference
[19]. LED, light-emitting diode
Table 1 Baseline characteristics of the microcirculation of 13 patients observed during weaning attempts
Baseline characteristics Successful weaning (n = 10) Non-successful weaning (n = 3) Total p value
Number of patients in each group 10 3 13 0.02
Weaning attempts 13 6 19 0.32
Age 56 ± 17 41 ± 16 49 ± 18 0.43
Male gender 9 2 11 0.11
Etiology
PE 5 0 5 0.03
Post cardiotomy 2 1 3 1.0
ACS 1 1 2 1.0
Myocarditis 1 1 2 1.0
Intoxication 1 0 1 1.0
Days on ICU 15 (6–65) 30 (3–36) 20 (3–65) 0.72
Days of ECMO 5 (2–21) 21 (3–36) 13 (2–36) 0.02
WA p.p. 1.3 ± 0.7 2.0 ± 1.7 1.5 ± 0.5 0.21
Abbreviations: ACS acute coronary syndrome, ICU intensive care unit, PE pulmonary embolism, VA-ECMO veno-arterial extracorporeal membrane oxygenation,
p.p. per patient, WA weaning attempts
p values in italics are statistically significant
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maintained their values prior to the weaning attempt,
whereas these values decreased in the patients who
were NSW (Additional file 3: Figure S2A through
Additional file 4: Figure S2F). TVDss, PVDss and PPVss
were statistically significantly reduced following a flow re-
duction (from F100 to F50) in patients who were not NSW
(TVDss all vessels p = 0.001; PVDss all vessels p = 0.01;
PPVss all vessels p = 0.04; TVD small vessels p = 0.001;
PVDss small vessels p = 0.01; PPV small vessels p = 0.03).
The images acquired from the same sublingual area
during VA-ECMO 100% and 50% flow, were evaluated
visually and then quantified side by side by comparing
total small and large vessel densities (Fig. 3a and b see also
Additional file 5: Clip 1 and Additional file 6: Clip 2). In
SW patients, no or minimal alterations in microcircula-
tion were seen during VA-ECMO 100% and 50% flow. In
contrast, patients who were not SW had clear dete-
rioration in total small and large vessel densities during
VA-ECMO 50% flow (Additional file 7: Table S2A, B
and C). Figure 3c shows an example of successful and
not successful weaning attempts in the same patient.
TVD of all vessels and TVD of small vessels were
statistically reduced in the NSW patients during 50% VA-
ECMO flow compared to no change or even increased
values in SW patients. Examples of the recorded moving
images of the sublingual microcirculation of the two cat-
egories of patients can be found in Additional file 8.
A comparison of the microcirculatory parameters with
echocardiographic parameters values according to the pub-
lished Aissaoui criteria for weaning from VA-ECMO [9]
showed good correlation, especially with LVEF (r = 0.6214
and p = 0.01) (Additional file 7: Table S3).
Receiver operating characteristic (ROC) curves showed
the area under the curve (AUC) was 0.99 vs 0.93 vs 0.85 for
the TVDssF50 (small vessels) >12.2 mm/mm
2, LVEF > 15%
and aortic VTI > 11 cm (Additional file 9: Figure S3).
Likewise, the AUC was 0.91 vs 0.93 vs 0.85 for the
PVDssF50 (all vessels) > 14.8 mm/mm
2, LVEF > 15%
and aortic VTI > 11 cm.
After reanalyzing the data using the individual out-
come of weaning attempts as an endpoint, TVD was
highly predictive of a successful weaning attempt from
ECMO (Additional file 7: Table S4A and S4B). In three
weaning attempts, the outcome of SW and NSW pa-
tients did not match with the TVD changes in the
microcirculation, with false negative (n = 2) and false
positive (n = 1) values seen. The positive predictive value
of sustained microcirculation for successful weaning is
89%. Two of these three attempts were in the same pa-
tient. All unsuccessful weaning attempts were during
50% ECMO flow below the 14.3 mm/mm2 cutoff point
of TVDssF50 predicting successful weaning, when pooled
to determine the success of each weaning attempt
separately (Fig. 4a and b).
Discussion
The main finding in this study is that sustained sublin-
gual microcirculation during VA-ECMO flow reduction
in a convenient cohort sample of patients supported
with VA-ECMO during cardiogenic shock, can provide a
marker for the success of weaning from VA-ECMO.
Cardiogenic shock affects all organs and compromises
central hemodynamic cardiovascular function and con-
sequently tissue perfusion. Currently used strategies for
weaning from VA-ECMO are largely based on echocar-
diographic parameters. However, performing echocardi-
ography in the ICU is challenging [10]. The results of
the present study show that functional parameters of
microcirculation, including TVDss and PVDss, reflect
recovery from cardiogenic shock and predict successful
weaning from VA-ECMO. Patients who were success-
fully weaned had significantly higher baseline TVDss
and PVDss compared to those of patients who were not
successfully weaned. Even though global hemodynamics
were comparable between patients with and without
successful weaning, microcirculatory parameters were
significantly different. The occurrence of such disassoci-
ation between macro-circulation and microcirculation,
referred to as a loss of hemodynamic coherence, has
been described before in other conditions of cardiovas-
cular compromise [11, 23–28].
The microcirculatory approach presented in this study
could provide an alternative approach for the rapid as-
sessment of cardiac recovery from cardiogenic shock
during weaning attempts and/or in addition to echocar-
diographic evaluation. This approach could also be use-
ful for the echocardiographic assessment of the left
ventricular systolic function, especially in ICU patients
with poor echo windows. Cavarocchi et al. [8] used a
4-stage strategy to evaluate 50% VA-ECMO blood flow,
volume challenge and inotropic challenge during at least 1
hour of the continual monitoring of heart rate, blood
pressure, and right ventricle (RV) and left ventricle (LV)
function under transesophageal echocardiography. Wean-
ing was considered successful when both LV and RV
functions tolerated volume challenge and demonstrated
inotropic reserve. However, this strategy required intra-
venous sedation to tolerate transesophageal echocardiog-
raphy and an increased physical load in non-intubated
patients throughout the weaning attempt with need for
continuous therapeutic anticoagulation. A different ap-
proach involves the use of biomarkers as indicators of the
success of weaning; however, such markers appear very
late and seem inconclusive for determining the success of
weaning from VA-ECMO. The usefulness of biomarkers
in weaning from VA-ECMO, therefore, remains contro-
versial. In line with this limitation, Luyt et al. [29] reported
that in patients with refractory cardiogenic shock receiv-
ing VA-ECMO support, early measurements of cardiac
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biomarkers are not useful for identifying those who
would recover.
In a VA ECMO weaning study, Aissaoui et al. mea-
sured left ventricular functional parameters (e.g., LVEF,
VTI, TDSa) and found these to be good predictors of
successful weaning. However, such echocardiographic
assessment is limited to the evaluation of the left heart
function under the condition that there are sufficient
windows for analysis [9]. The echocardiography parame-
ters used in these weaning attempts, however, do not
provide information about the right heart function,
systemic hemodynamics or tissue perfusion, which also
deteriorate as a consequence of cardiogenic shock. Our
study shows that during weaning attempts, recovery
from cardiogenic shock is revealed in the microcircula-
tion, which agrees with total cardiac recovery upon
echocardiography.
Monitoring the microcirculation using direct vital
imaging with handheld microscopy has the potential to
be the technique of choice to assess tissue perfusion in
different phases of shock [27, 30]. The study described
in this paper illustrated that the assessment of sublingual
microcirculation and the echocardiographic evaluation of
cardiac function was acceptably matched in discriminating
Fig. 3 a Microcirculatory alterations in successfully weaned (SW) vs not successfully weaned (NSW) patients during weaning attempts with
baseline flow (F100) and 50% of the baseline flow (F50). Examples are shown of microcirculation in the same sublingual area in two patients during F100
and F50. Images were taken from a 51-year-old man, there was cardiac recovery 3 days after tentamen suicidii with 900 mg of amlodipine and 1600
mg of hydrochlorothiazide in the same sublingual area during a weaning attempt on day 3, with no alterations in microcirculation (F100, veno-arterial
extracorporeal membrane oxygenation (VA-ECMO) flow 6.1 L/min; mean arterial pressure (MAP) 77 mmHg and F50, VA-ECMO flow 3 L/min; MAP 74
mmHg). b Images were taken from a 26-year-old woman with stable human immunodeficiency virus infection (HIV) developed myocarditis and
biventricular heart failure. After 4 weeks, there was no improvement in cardiac function. The microcirculatory images were documented during four weaning
attempts without improvement. The same sublingual area was also used during the last weaning attempt, which showed obvious persisting
deterioration in microcirculation (blue zones) (F100, VA-ECMO flow 4.7 L/min; MAP 75 mmHg and F50, VA-ECMO flow 2.7 L/min; MAP 67 mmHg).
c Changes in total vessel density (TVD) in small vessels during non-successful (day 2, red) and successful (day 4, green) weaning attempts in patient 7.
This 65-year-old man suffered from cardiogenic shock after coronary artery bypass graft (CABG) surgery
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between patients who were and were not successfully
weaned. Microcirculatory evaluation was rapid since alter-
ations were observed within 2 minutes following a lower-
ing of ECMO flow.
Physiologically, this fast-adapting mechanism can also
be evaluated from fractional flow reserve (FFR) measure-
ments in coronary angiography. In these measurements,
the hyperemic phase after the resolution of stenosis also
occurs within 2 minutes [31]. Several studies have been
performed on microcirculatory alterations during ECMO
[32, 33] with differing results concerning the relationship
between global hemodynamics to the microcirculation
[23, 34–38]. In a recent study, however, we found a sig-
nificant predictive value of sublingual measured perfused
vessel density in VA-ECMO patients for survival in the
ICU [11]. However, to date, sublingual measurements have
not been employed to guide weaning from VA-ECMO.
Limitations
The authors acknowledge the following limitations. First,
this was a single-center observational study with a small
population of patients with various underlying diseases
causing cardiogenic shock. Furthermore, analyses of
echocardiography and global hemodynamics, together
with microcirculatory parameters measured in the same
sublingual area, were performed only in patients deemed
eligible to wean. This meant that we could not perform
microcirculatory measurements without echocardiog-
raphy for weaning attempts in patients under VA-
ECMO support because of the observational nature.
The methods of measurement and evaluation of the
microcirculation remain sensitive to artifacts and tech-
nical limitations. The strength of our study from a meth-
odological perspective, however, lies in the fact that all
measurements were performed in the same area (single
spot). This methodology allowed us to assess the
response of single microvessels to changes in pump
settings as against comparing the mean value of micro-
circulation parameters of images at different locations
and at different time points.
Conclusion
We found that the functional microcirculatory parame-
ters measured sublingually using IDF imaging (TVDssF50
and PVDssF50) during weaning attempts for patients
from VA-ECMO showed essential alterations within 2
minutes and prediction of cardiac recovery after cardio-
genic shock. Future clinical and possible crossover
studies should be designed in larger study populations
undergoing VA-ECMO for monitoring microcirculation
to guide weaning attempts.
Key messages
 Veno-arterial extracorporeal membrane oxygenation
(VA-ECMO) use is a last option for survival in
many types of cardiogenic shock (CS).
 Conventional weaning from VA-ECMO is guided by
echocardiographic parameters such as the aortic
velocity − time integral on continuous wave Doppler
recordings from left ventricular outflow tract and by
assessing improvement in left ventricular ejection
fraction. Echocardiographic measurements are not
easily obtained in the ICU settings. On the other
hand, a novel imaging technique, dark field imaging
of the microcirculation, is quite feasible in almost all
patients in the ICU.
 Identified sublingual microcirculation is a novel
potential marker for identifying successful weaning
Fig. 4 a Data from individual successful weaning attempts (n = 10),
in which 8 demonstrated sustained or increased total vessel density
(TVD) independently from extracorporeal membrane oxygenation
(ECMO) flow. Two weaning attempts showed decreased TVD after
reducing the ECMO flow. b Data from individual unsuccessful
weaning attempts (n = 9), in which 8 demonstrated non-sustained
or declining TVD during 50% ECMO flow. One weaning attempt
showed sustained TVD after reducing the ECMO flow in contrast to
clinical judgment. However, the TVD was lower than the cutoff
14.3 mm/mm2
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from VA-ECMO. Sustained values of single-spot
measurements of total vessel density during 50% flow
reduction (TVDssF50) and single-spot measurements
of perfused vessel density during 50% flow reduction
(PVDssF50) were found to be specific and sensitive
indicators of successful weaning fromVA-ECMO
as compared to echocardiographic parameters.
Therefore, weaning fromVA-ECMO could be
performed by imaging of the microcirculation
using simple markers of tissue perfusion during
weaning attempts.
Additional files
Additional file 1: Table S1. Shows technical overview of the SDF and
IDF devices (adapted with permission from van Elteren et al. [19]).
(DOCX 12 kb)
Additional file 2: Figure S1. a Mean arterial pressure (MAP) and
b heart rate (HR) in patients successfully weaned (SW) and not
successfully weaned (NSW). (TIF 2047 kb)
Additional file 3: Figure S2. a Total vessel density (TVD), b perfused
vessel density (PVD) and c portion of the perfused vessels (PPV) in all
vessels (length between 25 and 100 μm) at flow time points of 100%
ECMO flow (F100) and 50% ECMO flow (F50) are compared between
patients successfully and not successfully weaned (SW and NSW,
respectively). (TIF 3043 kb)
Additional file 4: Figure S2. a TVD, b PVD and c PPV in small vessels
(capillaries < 25 μm) were compared between each patient during
weaning attempts at flow time points of 100% ECMO flow (F100) and
50% ECMO flow (F50) are compared between patients successfully and
not successfully weaned (SW and NSW, respectively). (TIF 2730 kb)
Additional file 5: Clip 1 shows movie of a patient with successful
weaning attempt. Microcirculatory image clips recorded during a
weaning attempt. (MOV 3029 kb)
Additional file 6: Clip 2 shows movie of a patient with non-successful
weaning attempt. Microcirculatory image clips recorded during a
weaning attempt. (MP4 749 kb)
Additional file 7: Table S2A. Shows microcirculatory changes during
weaning attempts. Table S2B. Shows microcirculatory differences at
baseline VA-ECMO flow. Table S2C. shows microcirculatory differences
between baseline and reduced VA-ECMO flow. Table S3. Shows correlation
between microcirculatory and echocardiographic parameters for the
prediction of successful weaning from VA-ECMO. Table S4A. Shows
comparison of the ROC curves of microcirculatory and echocardiographic
parameters for the prediction of successful weaning from VA-ECMO.
Table S4B. Shows comparison of the ROC curves of microcirculatory and
echocardiographic parameters for the prediction of successful weaning
from VA-ECMO. (DOCX 27 kb)
Additional file 8: Additionale data. (DOCX 13 kb)
Additional file 9: Figure S3. Receiver operating characteristic (ROC)
curves for significantly different values from microcirculation and
echocardiography as the best parameter from microcirculation and
echocardiography according to the area under the ROC curve (AUC).
A cutoff value of TVDssF50 > 12.2 mm/mm
2 (small vessels) has a higher
sensitivity, specificity, and AUC (0.99, 95% CI (0.78–1.00) vs 0.85, 95% CI
(0.596–0.97)) compared with aortic VTI F50 > 11 cm and compared with
LVEF >15% (0.99, 95% CI (0.78–1.00) vs 0.93 95% CI (0.67–0.997)).
(TIF 1258 kb)
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AUC: Area under the curve; CS: Cardiogenic shock; F50: Decreasing the
veno-arterial extracorporeal membrane oxygenation flow to 50% of the
baseline flow; ICU: Intensive care unit; IDF: Incident dark field; LVEF: Left
ventricular ejection fraction; NSW: Not successfully weaned; PPV: Proportion
of perfused vessels; PVD: Perfused vessel density; PVDss: Single-spot
measurements of perfused vessel density; PVDssF50: Single-spot
measurements of perfused vessel density during 50% flow reduction;
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spot; SW: Successfully weaned; TAPSE: Tricuspid annular planer systolic
excursion; TDSa: Tissue Doppler lateral mitral annulus peak systolic velocity;
TVD: Total vessel density; TVDss: Single-spot measurements of total vessel
density; TVDssF50: Single-spot measurements of total vessel density during
50% flow reduction; VA-ECMO: Veno-arterial extracorporeal membrane
oxygenation; VTI: Aortic velocity-time-integral; VTIF50: Aortic velocity–time
integral at 50% flow reduction; WA: Weaning attempt
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